semaglutide alzheimer clinical trial Semaglutide, exenatide, and their relatives are transforming diabetes and obesity care. Because their target also sits on brain cells, research into whether they slow Alzheimer's and Parkinson's has exploded: from 2 papers semaglutide alzheimer's clinical trial ameliorates

Ozempic and a host of similar GLP-1 drugs have officially entered the zeitgeist

These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements

The proposed effects of sermorelin (increased lean muscle mass, improved sleep quality, enhanced recovery, and metabolic benefits) remain largely theoretical or anecdotal in adults without documented growth hormone deficiency

Discontinuation is a dose-tolerability and titration problem, not a compound problem

The EHR cohort was younger and had a larger proportion of men than the survey cohort (median age 44 years versus 52 years, and 37% male versus 18%), and both of these factors may contribute to some of the apparent difference in weight loss efficacy between self-report and EHR data

Book your consultation now